Illumina Inc
Symbol: ILMN (NASDAQ)
96.37
▼ (-2.62%) -2.595
Company Description:
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Key Stats
- Today's Open: $98.39
- Today's High: $99.418
- Today's Low: $95.916
- Today's Volume: 726.78K
- Yesterday Close: $98.96
- Yesterday High: $102.305
- Yesterday Low: $98.505
- Yesterday Volume: 1.32M
- Last Min Volume: 2.22K
- Last Min High: $96.365
- Last Min Low: $96.313
- Last Min VWAP: $96.36345
Company Profile
- Name: Illumina Inc
- Website: https://www.illumina.com
- Listed Date: 2000-07-28
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001110803
- SIC Code: 3826
- SIC description: LABORATORY ANALYTICAL INSTRUMENTS
- Market Cap: $15.21B
- Round Lot: 100
- Outstanding Shares: 153.70M
- Asset Type: CS
RECENT FILINGS FOR ILMN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-07 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-01 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-07-08 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-23 | 8-K | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 8-K | View |
Latest News on ILMN